Aims-To evaluate the role of nitric oxide (NO) in ocular involvement during systemic toxoplasmosis.
Abstract
Aims-To evaluate the role of nitric oxide (NO) in ocular involvement during systemic toxoplasmosis. Methods-C57BV6 mice were infected with Toxoplasma gondii strain ME49. The synthesis of NO was inhibited by an intraperitoneal injection of aminoguanidine every 8 hours, starting on the day ofinfection. Control infected mice received phosphate buffered saline vehicle alone. After 14 days, the ocular lesions were evaluated by histopathological examination. The expression of NO synthase induced in the spleen by toxoplasma infection was evaluated by immunostaining. The production of NO by the spleen cells of infected mice was measured by the colorimetric assay of Griess in the supernatant of cultures stimulated with toxoplasma antigen or concanavalin A. Results-The inhibition of NO production in T gondii infected mice resulted in a marked increase in the symptoms of ocular inflammation. We observed a strong induction of NO synthase expression in the spleen of infected animals. In culture, the spleen cells from these mice produced high levels of NO in response to Tgondii antigens. This elevation of NO synthesis was suppressed in the presence of aminoguanidine. Conclusion-This study indicates that NO plays a crucial role in the protection against T gondii infection as reflected by the severity of the ocular involvement. (BrJ Ophthalmol 1996; 80:644- Figure 1 . The inflammation r, PA, score in these mice compared with the infected anol 18 controls was significantly augmented in the ates in retina (p=0.002), the choroid (p<0.001), and owave the vitreous (p=0.016) (Fig 2) . The eyes of for 30 non-infected mice treated with aminoguaniinding dine were normal (data not shown).
:ion at Infection with T gondii induced a strong D mM expression of NOS in the spleen of the mice 7.5 + (Fig 3) . As a competitor for the substrate of the -lysine enzyme, aminoguanidine does not affect NOS same expression (data not shown). In culture of the 00 ml infected mice spleen cells, the addition of toxon. The plasma antigen triggered a fourfold increase in ,clonal NO production (p<0.001) ( concanavalin A. However, the cells from infected mice secreted the same quantity of NO after concanavalin A stimulation than after antigenic stimulation, indicating that the larger part of the mechanism responsible for NO production had been induced in vivo by the toxoplasma infection. The synthesis of NO in these cultures was inhibited in the presence of aminoguanidine (Table 1) .
Discussion
We have shown that immune cells from Tgondii infected mice are driven to produce high levels of NO, and that the in vivo inhibition of this response leads to severe damage to the eye by the infection. From these observations we conclude that endogenously produced NO plays a protective role against the development of ocular lesions in toxoplasmosis. T gondii is an obligate intracellular parasite. The ability to inhibit the replication of or to kill the organism is dependent on several metabolic pathways.9 23 The production of reactive nitrogen intermediates is now considered to be one of the most important means of intracellular microbial killing. 24 25 The activation of lymphocytes by toxoplasma laden macrophages leads to the production of a large array of lymphokines such as interferon y, tumour necrosis factor a, and interleukin 1. In turn these cytokines were shown to mediate the signal for the production of NO by leucocytes.'"'8 We recently reported that the neutralisation of interferon y and tumour necrosis factor a with monoclonal antibodies dramatically enhances the ocular damage in C57BL/6 mice infected with T gondii. '6 In other models of infectious diseases such as leishmaniasis and listeriosis, a similar cycle of activating cytokines and NO production has been implicated in the immune response.29 30 In parallel with its cytotoxic effect on intracellular infective agent, NO has been shown to inhibit lymphocyte proliferation.'"' In our model we have also reported that NO production, induced in spleen cells of T gondii infected mice, was responsible for this inhibition of the lymphocyte response.'4 It was consequently assumed that the increase in the inflammatory response following treatment with aminoguanidine contributes to the enhanced severity of the lesions of toxoplasmosis.
The potential production of NO by ocular tissue cells during toxoplasma infection has not been studied yet. However, the inducible form of NO synthase was found to be expressed in the Muller cells of patients with cytomegalovirus retinitis.'4 The human retinal pigment epithelium also produces NO in culture when stimulated by interferon y and interleukin 1.15 These observations suggest that Muller cells and the retinal pigment epithelium may possibly participate in the local defence against T gondii. The occurrence of toxoplasma retinochoroiditis during systemic corticosteroid treatment35 36 and in AIDS patients"7 could be related to an accompanying deficit of NO production in both of these conditions. In AIDS, the lymphokines required for NO production are reduced in proportion to the severe depletion in T cell number.3" The expression of the NO synthase gene is also inhibited by corticosteroids.'9 It is a common practice to add corticosteroids to the antibiotic regimen in severe sight threatening toxoplasmosis. In view of the negative regulation of NO production by corticosteroids, the use of anti-inflammatory drugs devoid of effect on NO synthase should be considered. Future studies, examining the possibility and conditions of a local production of NO by organ specific cells as well as by infiltrating inflammatory cells during ocular 647 group.bmj.com on June 21, 2017 -Published by http://bjo.bmj.com/ Downloaded from toxoplasmosis, might help in the design of a more appropriate therapeutic management.
